TGFB1 and chronic kidney disease: α-SMA and TGF-β1 have been shown to stimulate proliferation in mesangial cells and increase the synthesis of extracellular matrix (ECM), and both have been identified as key mediators of glomerular and tubulointerstitial pathologies in chronic renal diseases.